Seminars in Liver Disease

Papers
(The H4-Index of Seminars in Liver Disease is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns82
Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?42
A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD33
Hepatic Extracellular Matrix and Its Role in the Regulation of Liver Phenotype33
Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma32
Patient-Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease27
HBV Biomarkers and Their Role in Guiding Treatment Decisions26
Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease25
Genetic and Epigenetic Basis of Drug-Induced Liver Injury24
Emerging Targets for the Treatment of Primary Sclerosing Cholangitis23
Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies18
Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy18
Alcohol Plus Additional Risk Factors: Rodent Model of Liver Injury17
Role of YAP1 Signaling in Biliary Development, Repair, and Disease16
Mice Engrafted with Human Liver Cells16
Wilson Disease: Novel Diagnostic and Therapeutic Approaches16
0.026991844177246